GlassScriptPhysician profile
Kassamo Dayemo
NPI 1811941982
$2,554.02
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $334 · 2021: $702 · 2022: $400 · 2023: $246 · 2024: $15.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $833.72 | 2019-2023 | Mavyret |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $407.67 | 2019-2024 | Trulance, Xifaxan |
| Braintree Laboratories, INC. | $405.45 | 2019-2023 | Sutab |
| Medical Device Business Services, INC. | $124.31 | 2019 | |
| Gilead Sciences, INC. | $114.83 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $104.66 | 2019 | |
| Ardelyx, INC. | $95.48 | 2023 | Ibsrela |
| Janssen Biotech, INC. | $93.26 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.88 | 2019-2021 | |
| Redhill Biopharma INC. | $58.31 | 2021-2022 | |
| Alfasigma USA, INC. | $40.62 | 2020 | |
| Ironwood Pharmaceuticals, INC | $33.22 | 2021-2023 | Linzess |
| Shionogi INC | $32.15 | 2019 | |
| Allergan, INC. | $26.31 | 2019-2020 | |
| Boston Scientific Corporation | $21.03 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $19.75 | 2020 | |
| Axonics, INC. | $18.98 | 2022 | |
| Pfizer INC. | $15.61 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.08 | 2021 | |
| Travere Therapeutics, INC. | $12.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kassamo Dayemo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.